Pages that link to "Q28294743"

The following pages link to Binding of two growth factor families to separate domains of the proteoglycan betaglycan (Q28294743):

Displaying 41 items.

• Expression of proteoglycan core proteins in human bone marrow stroma (Q24531861) (← links)
• Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites (Q24673586) (← links)
• Surface modification of implants in long bone (Q27010358) (← links)
• Specific stimulation of basal lamina heparan sulfate proteoglycan in mouse uterine epithelium by Matrigel and by transforming growth factor-beta 1 (Q28243923) (← links)
• Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos (Q28508310) (← links)
• Transforming growth factor beta receptor 3 (Q28562750) (← links)
• CSPG4: a prototype oncoantigen for translational immunotherapy studies. (Q33862585) (← links)
• Roles for the type III TGF-beta receptor in human cancer (Q33872593) (← links)
• Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer. (Q33892756) (← links)
• The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans (Q34031745) (← links)
• Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion (Q34081397) (← links)
• Fibroblast Growth Factor-2 Promotes in Vitro Mitral Valve Interstitial Cell Repair through Transforming Growth Factor-β/Smad Signaling (Q34756222) (← links)
• The cytoplasmic domain of TGFβR3 through its interaction with the scaffolding protein, GIPC, directs epicardial cell behavior (Q35243583) (← links)
• Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment (Q36108833) (← links)
• Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix (Q36232875) (← links)
• Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma (Q37259264) (← links)
• Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice (Q37284160) (← links)
• Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. (Q37475741) (← links)
• More than an accessory: implications of type III transforming growth factor-beta receptor loss in prostate cancer (Q37672642) (← links)
• Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. (Q38736415) (← links)
• The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. (Q40241912) (← links)
• Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules (Q40412665) (← links)
• Cytokines and proteoglycans (Q40910756) (← links)
• Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation (Q41177526) (← links)
• Fibroblast growth factor enhances expression of TGFβ-stimulated-clone-22 gene in osteoblast-like cells (Q41273375) (← links)
• Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling (Q41607558) (← links)
• Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface (Q41901900) (← links)
• Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells (Q42113999) (← links)
• The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase (Q42578955) (← links)
• Expression of cell-surface proteoglycan mRNA by human articular chondrocytes (Q42821447) (← links)
• Transforming growth factor-beta inhibits aromatase gene transcription in human trophoblast cells via the Smad2 signaling pathway (Q42948406) (← links)
• Dually modified transmembrane proteoglycans in development and disease (Q47240245) (← links)
• Proteoglycans with affinity for the neuralizing factor and the vegetalizing factor (activin A homologue). (Q47678272) (← links)
• Transforming growth factor beta 1-hyaluronic acid interaction (Q71993035) (← links)
• Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury (Q74096691) (← links)
• Specificity, versatility, and control of TGF-β family signaling (Q91943837) (← links)
• Betaglycan (TβRIII) is a Key Factor in TGF-β2 Signaling in Prepubertal Rat Sertoli Cells (Q91963152) (← links)
• Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins (Q92043470) (← links)
• MicroRNA let-7-TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction (Q92544529) (← links)
• On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges? (Q98178411) (← links)
• Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity (Q99555914) (← links)